Emily Jordan Maxon, DO | |
36065 Santa Fe Ave, Fort Cavazos, TX 76544-5060 | |
(254) 288-8000 | |
Not Available |
Full Name | Emily Jordan Maxon |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 36065 Santa Fe Ave, Fort Cavazos, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770049314 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Emily Jordan Maxon, DO 2102286243, Jbsa Ft Sam Houston, TX 78234-4504 Ph: () - | Emily Jordan Maxon, DO 36065 Santa Fe Ave, Fort Cavazos, TX 76544-5060 Ph: (254) 288-8000 |
News Archive
VOA News profiles the recently established Vietnam Clinical HIV/AIDS Society (VCHAS), among the first professional medical organizations of any type in Vietnam. VCHAS "was set up with support from the U.S. Centers for Disease Control through the Harvard Medical School AIDS Initiative, as part of the U.S. President's Emergency Plan for AIDS Relief," VOA notes.
Public health advisories from the U.S. Food and Drug Administration (FDA) and Health Canada were associated with significant reductions in the rate of dispensing of codeine to postpartum women, according to a study in the May 12 issue of JAMA.
Nektar Therapeutics announced today that the first patients have been dosed in a new Phase 1 dose-escalation clinical study to evaluate NKTR-102, the company's lead oncology compound, in combination with 5-fluorouracil (5-FU)/leucovorin in refractory solid tumor cancers. The study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio.
This week, Yoplait, in partnership with Susan G. Komen for the Cure, launched Know Your Girls, an interactive campaign that empowers young women to learn about breast cancer risk factors - and then share this knowledge with their circle of friends.
Adding corticosteroids to standard intravenous (IV) immunoglobulin treatment for children with Kawasaki disease judged to be at higher risk of developing blood vessel complications made initial treatment more successful and prevented these complications.
› Verified 9 days ago